Semiannual Securities Report — FY2026 H1
What SYSMEX CORPORATION reported for the period from 2026-04-01 to 2027-03-31.
Filed 2026-11-12View the original on EDINET
How much it says
62Detailed
What moved here
37named for the first time
Its own wording
23terms
Which filing this is
36/ 36newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the interim consolidated accounting period, sales increased in Japan and overseas following, among other developments, the acquisition on 1 April 2026 of all shares of シスメックスBioMajesty株式会社, the company through which the JEOL medical equipment business was transferred. The Group also disclosed progress in research and development activities and product-related developments involving p-Tau217 reagents, CYFRA reagents, OncoGuide PlasmaSeq and ADAMTS13 activity reagents.
Komori's summary of this document, not the document's own words.62Detailed
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 37 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
73
Detailed
68
Detailed
93
Very detailed
62
Detailed
0
Almost nothing
53
Typical
77
Very detailed
62
Detailed
53
Typical
79
Very detailed
50
Typical
R&D spend142億円Money spent making new things.
Cash left over341億円Cash from the business, less what went into equipment.
Spent on equipment133億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.